CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,055 | -47.6% | 151,093 | 0.0% | 0.00% | – |
| Q2 2023 | $542,424 | +5.9% | 151,093 | -0.6% | 0.00% | – |
| Q1 2023 | $512,216 | +8.7% | 151,993 | -50.0% | 0.00% | – |
| Q4 2022 | $471,178 | +120.2% | 303,986 | +92.9% | 0.00% | – |
| Q3 2022 | $214,000 | -38.0% | 157,593 | 0.0% | 0.00% | – |
| Q2 2022 | $345,000 | -85.0% | 157,593 | -78.2% | 0.00% | – |
| Q1 2022 | $2,305,000 | -23.7% | 722,689 | +0.3% | 0.00% | – |
| Q4 2021 | $3,020,000 | -48.5% | 720,788 | -0.2% | 0.00% | – |
| Q3 2021 | $5,862,000 | +8.7% | 721,967 | +1.1% | 0.00% | – |
| Q2 2021 | $5,394,000 | -5.5% | 714,410 | +8.6% | 0.00% | – |
| Q1 2021 | $5,710,000 | +11.2% | 657,786 | +2.1% | 0.00% | – |
| Q4 2020 | $5,136,000 | +5.0% | 644,410 | +5.1% | 0.00% | – |
| Q3 2020 | $4,891,000 | -11.7% | 613,230 | +9.6% | 0.00% | – |
| Q2 2020 | $5,540,000 | +32.9% | 559,612 | +3.8% | 0.00% | – |
| Q1 2020 | $4,167,000 | +96.1% | 539,082 | -2.4% | 0.00% | – |
| Q4 2019 | $2,125,000 | -17.3% | 552,076 | +8.1% | 0.00% | – |
| Q3 2019 | $2,568,000 | -25.6% | 510,536 | -2.3% | 0.00% | – |
| Q2 2019 | $3,453,000 | -5.5% | 522,438 | +8.2% | 0.00% | – |
| Q1 2019 | $3,654,000 | -3.8% | 482,747 | +2.7% | 0.00% | – |
| Q4 2018 | $3,799,000 | -37.4% | 470,195 | -0.0% | 0.00% | – |
| Q3 2018 | $6,067,000 | +22.4% | 470,327 | +8.2% | 0.00% | – |
| Q2 2018 | $4,956,000 | +3139.2% | 434,632 | +1914.1% | 0.00% | – |
| Q1 2018 | $153,000 | +25.4% | 21,579 | +15.4% | 0.00% | – |
| Q4 2017 | $122,000 | +64.9% | 18,705 | +55.9% | 0.00% | – |
| Q3 2017 | $74,000 | +45.1% | 12,000 | 0.0% | 0.00% | – |
| Q2 2017 | $51,000 | -5.6% | 12,000 | 0.0% | 0.00% | – |
| Q1 2017 | $54,000 | -16.9% | 12,000 | 0.0% | 0.00% | – |
| Q4 2016 | $65,000 | -15.6% | 12,000 | 0.0% | 0.00% | – |
| Q3 2016 | $77,000 | +40.0% | 12,000 | 0.0% | 0.00% | – |
| Q2 2016 | $55,000 | +17.0% | 12,000 | 0.0% | 0.00% | – |
| Q1 2016 | $47,000 | -29.9% | 12,000 | 0.0% | 0.00% | – |
| Q4 2015 | $67,000 | -10.7% | 12,000 | 0.0% | 0.00% | – |
| Q3 2015 | $75,000 | +2.7% | 12,000 | 0.0% | 0.00% | – |
| Q2 2015 | $73,000 | -53.8% | 12,000 | 0.0% | 0.00% | – |
| Q1 2015 | $158,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |